Отправить статью по E-mail 
Молекулярные методы диагностики гиперплазии эндометрия
- Авторы: Слюсарева О.А.1
-
Учреждения:
- Российский университет дружбы народов
- Выпуск: № 2 (2016)
- Страницы: 176-180
- Раздел: Статьи
- URL: https://journals.rudn.ru/medicine/article/view/3347
Цитировать
Полный текст
Аннотация
В статье описываются современные молекулярные методы диагностики гиперплазии эндометрия.
Ключевые слова
Об авторах
Ольга Александровна Слюсарева
Российский университет дружбы народов
Email: Lelechka.86@mail.ru
Список литературы
- Abike F., Tapisiz O.L., Zergeroglu S., et al. PCNA and KI-67 in endometrial hyperplasias and evaluation of the potential of malignancy. Eur. J. Gynaecol. Oncol. 2011. Vol. 32. No. 1. P. 77-80.
- Allison K.H., Upson K., Reed S.D. et al. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia. Int. J. Gynecol. Pathol. 2012. Vol. 31. No. 2. P. 151-159.
- Amalinei C., Cianga C., Balan R. et al. Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium. Ann. Anat. 2011. Vol. 193. No. 1. P. 43-55.
- Antonsen S.L., Ulrich L., Høgdall C. Patients with atypical hyperplasia of the endometrium should be treated in oncological centers. Gynecol. Oncol. 2012. Vol. 125. No. 1. P. 124-128.
- Armstrong A.J., Hurd W.W., Elguero S. et al. Diagnosis and management of endometrial hyperplasia. J. Minim. Invasive. Gynecol. 2012. Vol. 19. No. 5. P. 562-571.
- Chernuha G.E., Dumanovskaya M.R. Current views on endometrial hyperplasia. Obstetrics and Gynecology. 2013. No. 3. P. 26-32.
- Chernuha G.E., Dumanovskaya M.R., Burmenskaya O.V. et al. Expression of genes which regulate apoptosis in different types of endometrial hyperplasia and endometrial carcinoma. Obstetrics and Gynecology. 2013. No. 1. P. 63-69.
- Daud S., Jalil S.S., Griffin M. Endometrial hyperplasia - the dilemma of management remains: a retrospective observational study of 280 women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011. Vol. 159. No. 1. P. 172-175.
- Gallos I.D., Ofinran O., Shehmar M. et al. Current management of endometrial hyperplasia-a survey of United Kingdom consultant gynaecologists. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011. Vol. 118. No. 2. P. 305-307.
- Gunderson C.C., Fader A.N., Carson K. et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol. Oncol. 2012. Vol. 125. No. 2. P. 477-482.
- Gynecology. Guidance for practical training: a training manual. Ed. V.E. Radzinsky. 3rd ed. GEOTAR Media, 2013. P. 552.
- Radzinsky V.E., Fuks A.M. Gynecology. GEOTAR-media, 2014. P. 1000.
- Lacey J.V.Jr., Chia V.M., Rush B.B. Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan. Int. J. Cancer. 2012. Vol. 131. No. 8. P. 1921-1929.
- Morotti M., Menada M.V., Moioli M. et al. Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. Gynecol. Oncol. 2012. Vol. 125. No. 3. P. 536-540.
- Pieczyńska B., Wojtylak S., Zawrocki A. et al. Analysis of PTEN, estrogen receptor α and progesterone receptor expression in endometrial hyperplasia using tissue microarray. Pol. J. Pathol. 2011. Vol. 62. No. 3. P. 133-138.
- Reproductive health: Manual guide. Ed. V.E. Radzinsky. Peoples’ Friendship University, 2011.
- Steinbakk A., Gudlaugsson E., Aasprong O.G. et al. Molecular biomarkers in endometrial hyperplasias predict cancer progression. Am. J. Obstet. Gynecol. 2011. Vol. 204. No. 4. P. 357e1-357e12.
